Monoclonal gammopathies with clinical significance in rheumatology

Authors

Keywords:

multiple myeloma, monoclonal gammapathies, immunoglobulin, xanthogranuloma, rheumatic-like cancer, intravascular lymphoma, amyloidosis

Abstract

Monoclonal gammapathies are a broad group of diseases from hematopoietic cells with variable clinical features and systemic or limited involvement. These entities could begin as a rheumatic disease, even previously to the diagnosis of MG. To describe five patients with rheumatic manifestations that lately were diagnosed as monoclonal gammapathies. We describe the more relevant features of five patients assisted in our rheumatology center. Four patients were diagnosed with multiple myeloma that begins as: 1) Schnitzler’s syndrome, 2) Adult-onset xanthogranuloma and amyloidosis, 3) multiple vertebral fracture, 4) acute kidney failure. The 5th patient has a vasculitis-like syndrome due to an intravascular lymphoma. The rheumatic-like syndromes are infrequent but we should take into account this diagnosis in our clinical practice for rapid diagnostic and correct treatment.

Downloads

Download data is not yet available.

Author Biography

Alejandro Antonio Reibaldi, Hospital José María Cullen. Servicio de Reumatología

Concurrente de segundo año en el servicio de reumatologia del Hospital Cullen de Santa Fe, Argentina

References

D. Lipsker. Monoclonal gammopathy of cutaneous significance: review of relevant concept. Review article. JEADV [internet] 2016 [agosto de 2019]. Disponible en: DOI: 10.1111/jdv.13847.

Manciola F; Stemberg E. Mieloma multiple e injuria renal. Hematologia [internet] 2013 [agosto 2019] Vol.17 N°3:256-265. Disponible en: www.sah.org.ar/revista/numeros/Vol17n3-Mieloma%20Multiple%20e%20injuria.pdf

Lee CK; Zangari M; Barlogia B; et al. Dialisys dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. BMT [internet] 2004 [agosto 2019]; 33:823-828. Disponible en: www.nature.com/articles/1704440.pdf

Lipsker D; The Schnitzler Syndrome. OJRD [internet] 2010 [agosto 2019], 5:38. Disponible en: http://www.ojrd.com/content/5/1/38, doi:10.1186/1750-1172-5-38

Finucci Curi P. Síndrome de Schnitzler tratado con canakinumab. Revista SAR [internet] 2019 [enero 2020]; 30 (3) 34-37.

Baykal C; Ekinci A; Kurtulos D; et al. Review: The clinical spectrum of xanthomatous lesions of the eyelids. IJD [internet] 2017 [septiembre 2019] 1-12. Disponible en:doi: 10.1111/ijd.13637.

Miguel D; Lukacs J; Illing T; Elsner P.Treatment of necrobiotic xanthogranuloma a systematic review. JEADV [internet] 2017 [agosto 2019] 31, 221–235. Disponible en: DOI: 10.1111/jdv.13786.

Wettle C; Springinsfeld G; Lipsker D. Cutaneous haemorrhage induced by minimal trauma as a sign of light chain‐associated amyloidosis. BJH [internet] 2012 [septiembre 2019]; 159, 383. Disponible en: doi:10.1111/bjh.12050.

Daoud M; Lust J; Kyle R; et al. Monoclonal gammopathies and asocieted skin disorders. AAD [internet] 1999 [julio 2019]; Volumen 40, numero 4 507-535. Disponible en: https://www.jaad.org/article/S0190-9622(99)70434-2/fulltext.

Baixauli R; Garcia N; Hernandez O; CALVO C; Campos Fernandez C. Aplastamiento vertebral no osteoporótico. REEMO [internet] 2004 [agosto 2019] 13(1):21-23. Disponible en: https://www.elsevier.es/es-revista-reemo-70-articulo-aplastamiento-vertebral-no-osteoporotico-13060566.

Leucouvet F; Vande Berg B; Maldague B; et al.Vertebral compression fractures in Multiple Myeloma.distribution and appearence at MR imaging. Radiology [internet] 1997 [agosto 2019] 204: 195-199.

Contte M; Isnardi S; Sieza Y. Enfermedad osea en el mieloma multiple. SAH [internet] 2010 [agosto 2019] vol 14 2:29-40. Disponible en: http://www.sah.org.ar/Revista/numeros/vol14.n2.29-40.pdf

Fiore N; Romano O; Cedola J; Lambre J. Diagnostico diferencial en aplastamientos vertebrales. Rev. Asoc. Arg. Ortop y traumatologia [internet] 2001 [agosto 2019]. Vol. 67, No 1, págs. 6- 15. Disponible en: https://www.aaot.org.ar/revista/1993_2002/2002/2002_1/670101.pdf

Edwards CM, Zhuang J, Mundy GR. The pathogenesis of the bone disease of multiple myeloma. Bone [internet] 2008 [agosto 2019]; 42: 1007-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474770/

Smith A; Wisloff F; Samsom D; et al. Guidelines on the diagnosis and management of multiple myeloma. BJH[internet] 2005 [agosto 2019] 132: 410-51. Disponible en: doi:10.1111/j.1365-2141.2005.05867.x

Garcia Muñoz R; Mediavilla S.; Robles de Castro D; et al. Intravascular large B cell lymphoma. Elsevier [internet] 2014 [agosto 2019] Leukemia Research Reports 3 (2014) 21–23. Disponible en: https://dx.doi.org/10.1016%2Fj.lrr.2013.12.002.

Parera MJ; Peresin Paz RM; Sutovsky DJ; y col. Linfoma intravascular a celulas B grandes. SAH [internet] 2014 [agosto 2019] vol 18 n3: 287-291. Disponible en: http://www.sah.org.ar/revista/numeros/vol.18n.3.287.291.pdf

Mnshi N; Longo D; Anderson K. Trastornos de celulas plasmáticas. En: Dan L. Longo et al. Editores. Harrison Principios de Medicina Interna. Decimo octava edicion. New York, USA: McGrawHill; 2012 936-944.

Published

2020-10-01

How to Cite

1.
Reibaldi AA, sager L, Calvo R, Ortiz A, Roverano S, Paira S. Monoclonal gammopathies with clinical significance in rheumatology. Rev. cuba. de Reumatol. [Internet]. 2020 Oct. 1 [cited 2025 Mar. 12];22(4 Extra.):e168. Available from: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/843